Whole Genome Sequencing (WGS)
Whole Genome Sequencing (WGS) is the most comprehensive genomic analysis method available, utilizing Next-Generation Sequencing (NGS) technologies to map an organism's entire genetic code—including both protein-coding exons and non-coding intronic or regulatory regions. By scanning 100% of the genome, WGS provides an uncompromised view of genetic variation when targeted gene panels or Whole Exome Sequencing (WES) fall short.
Key Features & Advantages
- Complete Genome Coverage: Reads all ~3 billion base pairs of the human genome, analyzing both coding and non-coding regions without genomic gaps.
- Comprehensive Variant Detection: Simultaneously identifies Single Nucleotide Variants (SNVs), Small Insertions/Deletions (Indels), Structural Variants (SVs), and Copy Number Variations (CNVs) in a single test.
- Non-Coding & Regulatory Region Analysis: Uncovers disease-causing mutations within promoters, enhancers, and deep intronic regions that regulate gene expression.
- Future-Proof Genomic Data: Sequenced genomic data can be re-analyzed indefinitely as medical science discovers new gene-disease associations, eliminating the need for re-testing.
Whole Genome (WGS) vs. Whole Exome (WES) vs. Clinical Exome (CES)
| Feature | Whole Genome Sequencing (WGS) | Whole Exome Sequencing (WES) | Clinical Exome Sequencing (CES) |
| Genomic Coverage | 100% of Genome (Coding + Non-coding) | ~1–2% of Genome (All Exons) | ~6,000–8,000 Disease-linked Genes |
| Structural Variant (SV/CNV) Detection | Superior (Precise breakpoint resolution) | Limited | Limited / Targeted |
| Deep Intronic Variants | Detectable | Not Detectable | Not Detectable |
| Primary Clinical Indication | Undiagnosed complex cases | Diagnostic odyssey / Rare diseases | Targeted rapid clinical diagnosis |
| Bioinformatics Data Load | Very High (~100 GB+ raw data) | Moderate / High | Low / Controlled |
Key Applications
- Undiagnosed & Rare Diseases: Resolving cases where conventional diagnostic testing and WES failed to identify the underlying etiology.
- Cancer Genomics & Precision Oncology: Profiling paired tumor-normal genomes to reveal complex somatic rearrangements and guide targeted therapies.
- Population Genomics & Biomarker Discovery: Mapping population-specific genomic references and discovering novel pathogenic genes.
- Personalized Pharmacogenomics: Evaluating an individual's complete pharmacogenomic profile to optimize drug efficacy and prevent adverse reactions.
The Nucleus Genetics Advantage: Powered by high-throughput NGS platforms, advanced bioinformatic alignment algorithms, and expert medical geneticists, we transform raw genomic data into actionable clinical insights.
Expert Support
Get Information About This Service
Our expert team is ready to answer your questions and offer tailored solutions.
Contact Form →